For instance, Yu et al. suggested that miR-96 functions as a tumor-suppressor miRNA by targeting the KRAS gene in pancreatic cancer (Yu et al., 2010), this may be due to the different pathways where miR-96 works in various cancers. This evidence concerns the gene KRAS and familial pancreatic carcinoma.